As European markets navigate the complexities of geopolitical tensions and fluctuating energy prices, investors are increasingly focused on growth opportunities amidst broader economic challenges. In this environment, companies with high insider ownership can be particularly appealing as they often signal strong alignment between management and shareholders, potentially driving robust earnings growth.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| Pharma Mar (BME:PHM) | 12.1% | 39.6% |
| MilDef Group (OM:MILDEF) | 10.3% | 31.1% |
| Kuros Biosciences (SWX:KURN) | 25.9% | 58.6% |
| KebNi (OM:KEBNI B) | 12% | 103.8% |
| Gold Road International (OB:GOLDR) | 35.9% | 89.8% |
| CTT Systems (OM:CTT) | 17.4% | 55.3% |
| Clavister Holding AB (publ.) (OM:CLAV) | 20.5% | 60.7% |
| CD Projekt Red (WSE:CDR) | 35.2% | 43.4% |
| Bonesupport Holding (OM:BONEX) | 10.6% | 32.2% |
| Bergen Carbon Solutions (OB:BCS) | 11.9% | 52% |
Here's a peek at a few of the choices from the screener.
Med Life (BVB:M)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Med Life S.A. is a private healthcare provider offering integrated medical services through its clinics and hospitals in Romania, with a market cap of RON5.95 billion.
Operations: The company's revenue segments include Clinics (RON1.27 billion), Corporate (RON332.30 million), Hospitals (RON919.37 million), Pharmacies (RON91.13 million), Stomatology (RON119.82 million), and Laboratories (RON373.81 million).
Insider Ownership: 36.5%
Earnings Growth Forecast: 97.9% p.a.
Med Life shows potential as a growth company with high insider ownership in Europe, despite recent financial challenges. The company reported a net loss of RON 27.8 million for the first half of 2026, but revenue increased to RON 1.75 billion from the previous year. While trading below its estimated fair value by 26.8%, Med Life is expected to achieve profitability within three years, with forecasted annual profit growth outperforming market averages and a strong future return on equity at 29.9%.
- Click here and access our complete growth analysis report to understand the dynamics of Med Life.
- According our valuation report, there's an indication that Med Life's share price might be on the cheaper side.
Absolent Air Care Group (OM:ABSO)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Absolent Air Care Group AB (publ) specializes in designing, developing, selling, installing, and maintaining air filtration units with a market cap of approximately SEK2.46 billion.
Operations: The company's revenue is primarily derived from its Industrial segment, which accounts for SEK1.04 billion, and the Commercial Kitchen segment, contributing SEK248.18 million.
Insider Ownership: 12.7%
Earnings Growth Forecast: 31.6% p.a.
Absolent Air Care Group, despite not having recent insider trading activity, is trading 43.1% below its estimated fair value, suggesting potential undervaluation. The company reported improved financials for the second quarter of 2026 with sales reaching SEK 328.97 million and net income at SEK 26.9 million. Earnings are forecast to grow significantly at 31.62% annually, outpacing the Swedish market's growth rate of 7.3%, while revenue is expected to increase by a moderate 10.8% per year.
- Click to explore a detailed breakdown of our findings in Absolent Air Care Group's earnings growth report.
- The analysis detailed in our Absolent Air Care Group valuation report hints at an inflated share price compared to its estimated value.
CD Projekt Red (WSE:CDR)
Simply Wall St Growth Rating: ★★★★★★
Overview: CD Projekt Red S.A., along with its subsidiaries, is involved in the production, publishing, and digital distribution of video games and related products in Poland, with a market cap of PLN23.19 billion.
Operations: The company generates revenue of PLN947.28 million from its video game production, publishing, and digital distribution activities.
Insider Ownership: 35.2%
Earnings Growth Forecast: 43.4% p.a.
CD Projekt Red, with significant insider ownership, reported strong half-year earnings with revenue at PLN 435.31 million and net income at PLN 249.11 million, reflecting growth from the previous year. The company is trading 76.5% below its estimated fair value, indicating potential undervaluation. Forecasts show robust annual earnings growth of 43.44%, outpacing the Polish market's average of 10.8%, while revenue is expected to rise by an impressive 35.1% per year.
- Get an in-depth perspective on CD Projekt Red's performance by reading our analyst estimates report here.
- Insights from our recent valuation report point to the potential overvaluation of CD Projekt Red shares in the market.
Key Takeaways
- Access the full spectrum of 214 Fast Growing European Companies With High Insider Ownership by clicking on this link.
- Searching for a Fresh Perspective? Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com